Adult, but not neonatal, human lymphoid progenitors respond to TLR9 ligation by producing functional NK-like cells

Experimental Hematology

Volumn 42, Issue 7, 2014, Pages 562-573.e3

  Vadillo, Eduardo ^a,b   Dorantes Acosta, Elisa ^a,c   Arriaga Pizano, Lourdes ^d   Chavez Gonzalez, Antonieta ^a   Reyes Maldonado, Elba ^b   Garrett, Karla P ^e   Mayani, Héctor ^a   Kincade, Paul W ^e   Pelayo, Rosana ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c Federico Gómez Children's Hospital   (Mexico)

^d HOSPITAL DE ESPECIALIDADES   (Mexico)

^e OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 15 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 3; INTERLEUKIN 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; LYMPHOID PROGENITOR CELL; NATURAL KILLER CELL; NEWBORN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 9;

EID: 84904887218     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.03.008     Document Type: Article

References (61)

1. Nagai Y., Garrett K.P., Ohta S., et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006, 24:801-812.
2. Takizawa H., Boettcher S., Manz M.G. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 2012, 119:2991-3002.
3. Welner R.S., Pelayo R., Kincade P.W. Evolving views on the genealogy of B cells. Nature reviews Immunology 2008, 8:95-106.
4. Welner R.S., Pelayo R., Nagai Y., et al. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood 2008, 112:3753-3761.
5. Welner R.S., Esplin B.L., Garrett K.P., et al. Asynchronous RAG-1 expression during B lymphopoiesis. J Immunol 2009, 183:7768-7777.
6. Yanez A., Flores A., Murciano C., O'Connor J.E., Gozalbo D., Gil M.L. Signalling through TLR2/MyD88 induces differentiation of murine bone marrow stem and progenitor cells to functional phagocytes inresponse to Candida albicans. Cellular microbiology 2010, 12:114-128.
7. Yanez A., Murciano C., O'Connor J.E., Gozalbo D., Gil M.L. Candida albicans triggers proliferation and differentiation of hematopoietic stem and progenitor cells by a MyD88-dependent signaling. Microbes Infect 2009, 11:531-535.
8. Downes J.E., Marshall-Clarke S. Innate immune stimuli modulate bone marrow-derived dendritic cell production invitro by toll-like receptor-dependent and -independent mechanisms. Immunology 2010, 131:513-524.
9. Megias J., Yanez A., Moriano S., O'Connor J.E., Gozalbo D., Gil M.L. Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs invivo and promotes differentiation toward macrophages. Stem Cells 2012, 30:1486-1495.
10. Baldridge M.T., King K.Y., Goodell M.A. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol 2011, 32:57-65.
11. McGettrick A.F., O'Neill L.A. Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. Br J Haematol 2007, 139:185-193.
12. Yanez A., Hassanzadeh-Kiabi N., Ng M.Y., et al. Detection of a TLR2 agonist by hematopoietic stem and progenitor cells impacts the function of the macrophages they produce. Eur J Immunol 2013, 43:2114-2125.
13. De Luca K., Frances-Duvert V., Asensio M.J., et al. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia 2009, 23:2063-2074.
14. Kim J.M., Kim N.I., Oh Y.K., Kim Y.J., Youn J., Ahn M.J. CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-kappaB-independent pathways. Int Immunol 2005, 17:1525-1531.
15. Vadillo E., Pelayo R. [Toll-like receptors in development and function of the hematopoietic system]. Rev Invest Clin 2012, 64:461-476.
16. Sioud M., Floisand Y., Forfang L., Lund-Johansen F. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J Mol Biol 2006, 364:945-954.
17. Sioud M., Floisand Y. TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response. Eur J Immunol 2007, 37:2834-2846.
18. Boiko J.R., Borghesi L. Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine 2012, 57:1-8.
19. Kim G.G., Donnenberg V.S., Donnenberg A.D., Gooding W., Whiteside T.L. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay. J Immunol Methods 2007, 325:51-66.
20. Cao L.F., Krymskaya L., Tran V., et al. Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis. Cytometry A 2010, 77:534-545.
21. Yoshida T., Saito A., Iwasaki Y., et al. Characterization of natural killer cells in tamarins: a technical basis for studies of innate immunity. Front Microbiol 2010, 1:128.
22. Bryceson Y.T., Fauriat C., Nunes J.M., et al. Functional analysis of human NK cells by flow cytometry. Methods Mol Biol 2010, 612:335-352.
23. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010, 11:585-593.
24. Dorantes-Acosta E., Vadillo E., Contreras-Quiroz A., et al. TLR stimulation of bone marrow lymphoid precursors from childhood acute leukemia modifies their differentiation potentials. Biomed Res Int 2013, 2013:846724.
25. Freud A.G., Caligiuri M.A. Human natural killer cell development. Immunol Rev 2006, 214:56-72.
26. Ikawa T., Fujimoto S., Kawamoto H., Katsura Y., Yokota Y. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc Natl Acad Sci U S A 2001, 98:5164-5169.
27. Grzywacz B., Kataria N., Blazar B.R., Miller J.S., Verneris M.R. Natural killer-cell differentiation by myeloid progenitors. Blood 2011, 117:3548-3558.
28. Williams N.S., Klem J., Puzanov I.J., Sivakumar P.V., Bennett M., Kumar V. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells. J Immunol 1999, 163:2648-2656.
29. Yu H., Fehniger T.A., Fuchshuber P., et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 1998, 92:3647-3657.
30. Prendergast A.J., Klenerman P., Goulder P.J. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 2012, 12:636-648.
31. Smith H.R., Heusel J.W., Mehta I.K., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 2002, 99:8826-8831.
32. Kawai T., Akira S. TLR signaling. Semin Immunol 2007, 19:24-32.
33. Pasare C., Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005, 438:364-368.
34. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
35. Cervantes-Barragan L., Gil-Cruz C., Pastelin-Palacios R., et al. TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens. Eur J Immunol 2009, 39:126-135.
36. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
37. Esplin B.L., Shimazu T., Welner R.S., et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol 2011, 186:5367-5375.
38. Schmid M.A., Takizawa H., Baumjohann D.R., Saito Y., Manz M.G. Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 2011, 118:4829-4840.
39. Pelayo R., Miyazaki K., Huang J., Garrett K.P., Osmond D.G., Kincade P.W. Cell cycle quiescence of early lymphoid progenitors in adult bone marrow. Stem Cells 2006, 24:2703-2713.
40. Yokota T., Kouro T., Hirose J., et al. Unique properties of fetal lymphoid progenitors identified according to RAG1 gene expression. Immunity 2003, 19:365-375.
41. Rossi M.I., Yokota T., Medina K.L., et al. B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood 2003, 101:576-584.
42. Mayani H. Biological differences between neonatal and adult human hematopoietic stem/progenitor cells. Stem Cells Dev 2010, 19:285-298.
43. Pelayo R., Dorantes-Acosta E., Vadillo E., Fuentes-Panana E.M. From HSC to B-lymphoid cells in normal and malignant hematopoiesis. Advances in Hematopoietic Stem Cell Research 2012, 277-299. InTech, Rijeka, Croatia. R. Pelayo (Ed.).
44. Nguyen M., Leuridan E., Zhang T., et al. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS One 2010, 5:e10407.
45. Kollmann T.R., Crabtree J., Rein-Weston A., et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009, 183:7150-7160.
46. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390.
47. Kollmann T.R., Levy O., Montgomery R.R., Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012, 37:771-783.
48. Kasturi S.P., Skountzou I., Albrecht R.A., et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011, 470:543-547.
49. Traycoff C.M., Abboud M.R., Laver J., Clapp D.W., Srour E.F. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced exvivo expansion potential. Exp Hematol 1994, 22:1264-1272.
50. Lee J., Lee S.H., Shin N., et al. Tumor necrosis factor-alpha enhances IL-15-induced natural killer cell differentiation. Biochem Biophys Res Commun 2009, 386:718-723.
51. Li W., Okuda A., Yamamoto H., et al. Regulation of development of CD56(bright)CD11c(+) NK-like cells with helper function by IL-18. PLoS One 2013, 8:e82586.
52. Tsuda J., Li W., Yamanishi H., et al. Involvement of CD56brightCD11c+ cells in IL-18-mediated expansion of human gammadelta T cells. J Immunol 2011, 186:2003-2012.
53. Jinushi M., Takehara T., Kanto T., et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 2003, 170:1249-1256.
54. Di Santo J.P., Vosshenrich C.A. Bone marrow versus thymic pathways of natural killer cell development. Immunol Rev 2006, 214:35-46.
55. Snell L.M., Lin G.H., Watts T.H. IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15. J Immunol 2012, 188:5915-5923.
56. Judge A.D., Zhang X., Fujii H., Surh C.D., Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med 2002, 196:935-946.
57. Yi Z., Stunz L.L., Bishop G.A. TNF receptor associated factor 3 plays a key role in development and function of invariant natural killer T cells. J Exp Med 2013, 210:1079-1086.
58. Ogawa M. Changing phenotypes of hematopoietic stem cells. Exp Hematol 2002, 30:3-6.
59. Benz C., Copley M.R., Kent D.G., et al. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell stem cell 2012, 10:273-283.
60. Elahi S., Ertelt J.M., Kinder J.M., et al. Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature 2013, 504:158-162.
61. Della Chiesa M., Falco M., Bertaina A., et al. Human Cytomegalovirus Infection Promotes Rapid Maturation of NK Cells Expressing Activating Killer Ig-like Receptor in Patients Transplanted withNKG2C-/- Umbilical Cord Blood. J Immunol 2014, 192:1471-1479.